Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

AQST Aquestive Therapeutics, Inc. Common Stock
$4.02 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy AQST stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 493.1M
Enterprise value 411.9M
Forward PE -6.9310346
PEG Ratio -6.9310346
Enterprise to EBITDA -5.845
Enterprise to revenue 9.248
Price to book MRQ -14.60182630027
Price to sales TTM 11.014055

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 44.5M
EBITDA -70477000
Diluted EPS TTM -0.78
Total Cash (MRQ) 121.2M
Current ratio (MRQ) 3.135
Operating Cash Flow (TTM) -52432000

AQST trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent AQST News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.